Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | UCPVax |
Synonyms | |
Therapy Description |
UCPVax is a peptide vaccine consisting of cancer peptides derived from the human telomerase reverse transcriptase catalytic subunit (TERT), which may lead to activation of the immune response and killing of tumor cells expressing telomerase (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
UCPVax | CD4-specific Telomerase Peptide Vaccine UCPVax | UCPVax is a peptide vaccine consisting of cancer peptides derived from the human telomerase reverse transcriptase catalytic subunit (TERT), which may lead to activation of the immune response and killing of tumor cells expressing telomerase (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04280848 | Phase Ib/II | UCPVax | Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma (UCPVax-Glio) | Active, not recruiting | FRA | 0 |
NCT02818426 | Phase Ib/II | UCPVax | Universal Cancer Peptide-based Vaccination in Metastatic NSCLC (UCPVax) | Active, not recruiting | FRA | 0 |